Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways

Cell Calcium

Volumn 58, Issue 2, 2015, Pages 196-207

  Barr, Jeffrey L ^a   Deliu, Elena ^a   Brailoiu, G Cristina ^b   Zhao, Pingwei ^a   Yan, Guang ^b   Abood, Mary E ^a   Unterwald, Ellen M ^a   Brailoiu, Eugen ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Calcium; Endoplasmic reticulum; Imaging; Nucleus accumbens; Sigma receptors; Transient receptor potential channels

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; COCAINE; DOPAMINE 1 RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHATIDYLINOSITOL; SIGMA 1 OPIATE RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; 1-(2-(3-(4-METHOXYPHENYL)PROPOXY)-4-METHOXYPHENYLETHYL)-1H-IMIDAZOLE; IMIDAZOLE DERIVATIVE; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL C;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HYPERACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MICROINJECTION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL STIMULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SENSITIZATION; ANIMAL; ANIMAL BEHAVIOR; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; MALE; MEMBRANE POTENTIAL; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; COCAINE; ENDOPLASMIC RETICULUM; IMIDAZOLES; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LOCOMOTION; MALE; MEMBRANE POTENTIALS; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; TRPC CATION CHANNELS;

EID: 84952628240     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2015.05.001     Document Type: Article

References (56)

1. Carroll F.I., Howell L.L., Kuhar M.J. Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J. Med. Chem. 1999, 42:2721-2736.
2. Gorelick D.A., Gardner E.L., Xi Z.X. Agents in development for the management of cocaine abuse. Drugs 2004, 64:1547-1573.
3. Rush C.R., Stoops W.W. Agonist replacement therapy for cocaine dependence: a translational review. Future Med. Chem. 2012, 4:245-265.
4. Chen R., Tilley M.R., Wei H., Zhou F., Zhou F.M., Ching S., Quan N., Stephens R.L., Hill E.R., Nottoli T., Han D.D., Gu H.H. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9333-9338.
5. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
6. Anderson S.M., Pierce R.C. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol. Ther. 2005, 106:389-403.
7. 2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J. Neurosci. 2008, 28:5671-5685.
8. 1 receptor mutant mice. Cell 1994, 79:945-955.
9. Sharkey J., Glen K.A., Wolfe S., Kuhar M.J. Cocaine binding at sigma receptors. Eur. J. Pharmacol. 1988, 149:171-174.
10. Hayashi T., Su T.P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:491-496.
11. Su T.P., Hayashi T., Maurice T., Buch S., Ruoho A.E. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol. Sci. 2010, 31:557-566.
12. Katz J.L., Su T.P., Hiranita T., Hayashi T., Tanda G., Kopajtic T., Tsai S.Y. A role for sigma receptors in stimulant self administration and addiction. Pharmaceuticals (Basel) 2011, 4:880-914.
13. Maurice T., Su T.P. The pharmacology of sigma-1 receptors. Pharmacol. Ther. 2009, 124:195-206.
14. Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., Maurice T. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 2000, 97:155-170.
15. Gundlach A.L., Largent B.L., Snyder S.H. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci. 1986, 6:1757-1770.
16. Matsumoto R.R. Targeting sigma receptors: novel medication development for drug abuse and addiction. Expert Rev. Clin. Pharmacol. 2009, 2:351-358.
17. Matsumoto R.R., Liu Y., Lerner M., Howard E.W., Brackett D.J. Sigma receptors: potential medications development target for anti-cocaine agents. Eur. J. Pharmacol. 2003, 469:1-12.
18. Hiranita T., Mereu M., Soto P.L., Tanda G., Katz J.L. Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology 2013, 38:605-615.
19. Hiranita T., Soto P.L., Tanda G., Katz J.L. Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine. J. Pharmacol. Exp. Ther. 2010, 332:515-524.
20. Romieu P., Martin-Fardon R., Maurice T. Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. Neuroreport 2000, 11:2885-2888.
21. Romieu P., Phan V.L., Martin-Fardon R., Maurice T. Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 2002, 26:444-455.
22. 1 receptor-mediated effects of cocaine. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18676-18681.
23. 2 receptor heteromers. PLoS ONE 2013, 8:e61245.
24. Hayashi T., Su T.P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 2007, 131:596-610.
25. Deliu E., Brailoiu G.C., Eguchi S., Hoffman N.E., Rabinowitz J.E., Tilley D.G., Madesh M., Koch W.J., Brailoiu E. Direct evidence of intracrine angiotensin II signaling in neurons. Am. J. Physiol. Cell Physiol. 2014, 306:C736-C744.
26. 2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms. Mol. Pharmacol. 2013, 84:190-200.
27. 1 dopamine receptors in rat brain. J. Neurochem. 2003, 85:378-386.
28. Matsumoto R.R., Bowen W.D., Tom M.A., Vo V.N., Truong D.D., De Costa B.R. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur. J. Pharmacol. 1995, 280:301-310.
29. Berardi F., Ferorelli S., Colabufo N.A., Leopoldo M., Perrone R., Tortorella V. A multireceptorial binding reinvestigation on an extended class of sigma ligands: N-[omega-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards sigma1 and EBP sites. Bioorg. Med. Chem. 2001, 9:1325-1335.
30. Chaki S., Okuyama S., Ogawa S., Tanaka M., Muramatsu M., Nakazato A., Tomisawa K. Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brain. Life Sci. 1996, 59:1331-1340.
31. Clapham D.E., Julius D., Montell C., Schultz G. International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels. Pharmacol. Rev. 2005, 57:427-450.
32. 2+ entry. J. Biol. Chem. 1998, 273:133-142.
33. Guse A.H. Calcium mobilizing second messengers derived from NAD. Biochim. Biophys. Acta 2014, 10.1016/j.bbapap.2014.12.015.
34. Kolisek M., Beck A., Fleig A., Penner R. Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels. Mol. Cell 2005, 18:61-69.
35. Togashi K., Hara Y., Tominaga T., Higashi T., Konishi Y., Mori Y., Tominaga M. TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. EMBO J. 2006, 25:1804-1815.
36. Venkatachalam K., Montell C. TRP channels. Annu. Rev. Biochem. 2007, 76:387-417.
37. Naylor E., Arredouani A., Vasudevan S.R., Lewis A.M., Parkesh R., Mizote A., Rosen D., Thomas J.M., Izumi M., Ganesan A., Galione A., Churchill G.C. Identification of a chemical probe for NAADP by virtual screening. Nat. Chem. Biol. 2009, 5:220-226.
38. Novakova M., Ela C., Bowen W.D., Hasin Y., Eilam Y. Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur. J. Pharmacol. 1998, 353:315-327.
39. Tsai S.Y., Hayashi T., Mori T., Su T.P. Sigma-1 receptor chaperones and diseases. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9:184-189.
40. Kurokawa K., Mizuno K., Shibasaki M., Ohkuma S. Regulation of type 1 inositol 1,4,5-triphosphate receptor by dopamine receptors in cocaine-induced place conditioning. Synapse 2012, 66:180-186.
41. Benuck M., Lajtha A., Reith M.E. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 1987, 243:144-149.
42. Pettit H.O., Pan H.T., Parsons L.H., Justice J.B. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J. Neurochem. 1990, 55:798-804.
43. Su T.P., Hayashi T. Cocaine affects the dynamics of cytoskeletal proteins via sigma(1) receptors. Trends Pharmacol. Sci. 2001, 22:456-458.
44. 1 dopamine receptor coupling to PLCbeta regulates forward locomotion in mice. J. Neurosci. 2013, 33:18125-18133.
45. Tannu N., Mash D.C., Hemby S.E. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol. Psychiatry 2007, 12:55-73.
46. Shioda N., Ishikawa K., Tagashira H., Ishizuka T., Yawo H., Fukunaga K. Expression of a truncated form of the endoplasmic reticulum chaperone protein, sigma1 receptor, promotes mitochondrial energy depletion and apoptosis. J. Biol. Chem. 2012, 287:23318-23331.
47. Wu Z., Bowen W.D. Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells. J. Biol. Chem. 2008, 283:28198-28215.
48. Franke H., Kittner H., Grosche J., Illes P. Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine. Psychopharmacology (Berl) 2003, 167:187-194.
49. Wilson C.J. The generation of natural firing patterns in neostriatal neurons. Prog. Brain Res. 1993, 99:277-297.
50. Wilson C.J., Kawaguchi Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J. Neurosci. 1996, 16:2397-2410.
51. Clapham D.E. TRP channels as cellular sensors. Nature 2003, 426:517-524.
52. Fowler M.A., Sidiropoulou K., Ozkan E.D., Phillips C.W., Cooper D.C. Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. PLoS ONE 2007, 2:e573.
53. Pomrenze M.B., Baratta M.V., Rasmus K.C., Cadle B.A., Nakamura S., Birnbaumer L., Cooper D.C. Cocaine self-administration in mice with forebrain knock-down of trpc5 ion channels. F1000Res. 2013, 2:53.
54. Rasmus K.C., O'Neill C.E., Bachtell R.K., Cooper D.C. Cocaine self-administration in rats lacking a functional trpc4 gene. F1000Res. 2013, 2:110.
55. 3 receptor complexes as key targets for reducing cocaine's effects. J. Neurosci. 2014, 34:3545-3558.
56. Kourrich S., Hayashi T., Chuang J.Y., Tsai S.Y., Su T.P., Bonci A. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 2013, 152:236-247.